Prognostic value of HALP score in non-small cell lung cancer (NSCLC) patients with first-line chemotherapy combined with immunotherapy: a real-world retrospective study
{{output}}
Backgrounds: Immune checkpoint inhibitors (ICIs) combined with platinum-containing chemotherapy are the standard first-line therapy for advanced or metastatic non-small cell lung cancer (NSCLC). However, individualization varies ... ...
